Velioglu C.Erdemli M.E.Gul M.Erdemli Z.Zayman E.Bag H.G.Altinoz E.2019-08-012019-08-0120190231-5882https://dx.doi.org/10.4149/gpb_2018039https://hdl.handle.net/11480/1569The objective of the present study was to demonstrate the protective effect of crocin on the adverse effects of tartrazine on liver. Crocin is a carotenoid and a strong free radical scavenger. Forty rats were randomly divided into 4 groups (n = 10). The first group was the control group (C) and saline solution was administered to this group. The second group (Cr) was administered 50 mg/ kg crocin. The third group (T) was administered 500 mg/kg tartrazine. The fourth group (T+Cr) was administered the same doses of both crocin and tartrazine as the previous groups for 21 days. It was determined that tartrazine increased liver superoxide dismutase (SOD) activity, malondialdehyde (MDA) and total oxidant status (TOS) levels and catalase (CAT) activity, decreased glutathione (GSH), and total antioxidant status (TAS) levels. Furthermore, tartrazine administration resulted in significant increases in plasma aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP) activities and pathological changes in the liver. When tartrazine administered rats were treated with crocin for 21 days, the biochemical parameters improved, and liver tissues were restored. Thus, it was demonstrated that crocin had protective effects on the adverse effects caused by tartrazine administration. © 2019, Slovak Academy of Sciences. All rights reserved.eninfo:eu-repo/semantics/closedAccessCrocinHepatotoxicityOxidative stressTartrazineArticle38738210.4149/gpb_2018039306574622-s2.0-85061474703Q3WOS:000458604800007Q4